Evaluation of blood TMB (bTMB) in KEYNOTE-189: Pembrolizumab (pembro) plus chemotherapy (chemo) with pemetrexed and platinum versus placebo plus chemo as first-line therapy for metastatic nonsquamous NSCLC.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Marina Chiara Garassino, Shirish M. Gadgeel, Delvys Rodriguez-Abreu, Enriqueta Felip, Emilio Esteban, Giovanna Speranza, Maximilian Hochmair, Steven Francis Powell, Edward B. Garon, Rina Hui, Naoyuki Nogami, Razvan Cristescu, Michael Morrissey, Andrey Loboda, Julie Kobie, Mark Ayers, Bilal Piperdi, Maria Catherine Pietanza, Alexandra Snyder, Martin Reck
Institutions: Fondazione IRCCS Istituto Nazionale dei Tumori, University of Michigan, The Barbara Ann Karmanos Cancer Institute, Universidad de Las Palmas de Gran Canaria, Hospital Universitario Insular de Gran Canaria, Vall d'Hebron Hospital Universitari, Hospital Universitario Central de Asturias, Université de Sherbrooke, Otto Wagner Hospital, Sanford Health, University of California, Los Angeles, The University of Sydney, Westmead Hospital, Shikoku Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States), German Center for Lung Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3029386751